Generics News

Generics News

InnoPharma Approved for Generic Dacogen

InnoPharma has announced that it has received approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Decitabine for Injection, a generic version of Eisai's Dacogen.

TWi Pharma Approved for Generic Megace ES

TWi Pharmaceuticals announced that it has received final approval for Megestrol Acetate Suspension, the generic version of Par Pharmaceutical's Megace ES.

Fera to Launch Generic Moxatag

Fera Pharmaceuticals announced it will launch Amoxicillin Extended-Release Tablets, the generic version of Pragma Pharmaceuticals' Moxatag.

Mylan Launches Generic Klor-Con Tablets

Mylan announced its launch of Potassium Chloride Extended-Release Tablets, the generic version of Upsher-Smith's Klor-Con.

Mylan Launches Generic Precedex

Mylan announced it has received final approval for its Abbreviated New Drug Application (ANDA) for Dexmedetomidine HCl Injection, the generic version of Hospira's Precedex.

Amneal Launches Four New Generic Products

Amneal announced the launch of four new generic medications: Acyclovir Ointment, Atovaquone Oral Suspension, Clindamycin Palmitate HCl for Oral Solution (Pediatric), and Oxycodone HCl Tablets.

Sanofi Launches Generic Eloxatin Injection

Sanofi announced the launch of Oxaliplatin Injection, the generic version of its Eloxatin.

Mylan Launches Generic Xeloda

Mylan announced the launch of Capecitabine Tablets, the generic version of Genentech's Xeloda.

Lannett Approved for Oxycodone HCl Capsules

Lannett announced it has received FDA approval of its Abbreviated New Drug Application (ANDA) for Oxycodone HCl Capsules.

Upsher-Smith Launches Generic Qudexy XR

Upsher-Smith announced the launch of Topiramate Extended-Release Capsules, the generic version of its recently approved Qudexy XR (topiramate) extended-release capsules.